Selective Antifungal Activity of Shorter Active Analogues of Bactenecin7 Against Fusarium moniliforme.

Abiraj, K.; Sachidananda, M. K.; Gowda, A. S. Prakasha; Gowda, D. Channe

doi:10.1002/chin.200426171

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Bac7, a cathelicidin-derived peptide of bovine neutrophil granules having antimicrobial properties has 59 amino acids with three tandem repeats of a tetra decamers, consisting several PRP triplets and single hydrophobic amino acid ( Figure 46 ). Therefore, the authors have chosen highly active tetrapeptides (GPRP and RPRP) from their earlier work [ 134 ], conjugated them to quinazolinone moiety and examined the antimicrobial activity. The results reported that tetrapeptide analogues showed a higher potent activity than their tri- and dipeptide analogues.…”

Section: Conjugated or Hybrid Moleculesmentioning

confidence: 99%

Conjugation as a Tool in Therapeutics: Role of Amino Acids/Peptides-Bioactive (Including Heterocycles) Hybrid Molecules in Treating Infectious Diseases

et al. 2023

View full text Add to dashboard Cite

Peptide-based drugs are gaining significant momentum in the modern drug discovery, which is witnessed by the approval of new drugs by the FDA in recent years. On the other hand, small molecules-based drugs are an integral part of drug development since the past several decades. Peptide-containing drugs are placed between small molecules and the biologics. Both the peptides as well as the small molecules (mainly heterocycles) pose several drawbacks as therapeutics despite their success in curing many diseases. This gap may be bridged by utilising the so called ‘conjugation chemistry’, in which both the partners are linked to one another through a stable chemical bond, and the resulting conjugates are found to possess attracting benefits, thus eliminating the stigma associated with the individual partners. Over the past decades, the field of molecular hybridisation has emerged to afford us new and efficient molecular architectures that have shown high promise in medicinal chemistry. Taking advantage of this and also considering our experience in this field, we present herein a review concerning the molecules obtained by the conjugation of peptides (amino acids) to small molecules (heterocycles as well as bioactive compounds). More than 125 examples of the conjugates citing nearly 100 references published during the period 2000 to 2022 having therapeutic applications in curing infectious diseases have been covered.

show abstract

Section: Conjugated or Hybrid Moleculesmentioning

confidence: 99%